Amiloxate
Names | |
---|---|
IUPAC name
3-Methylbutyl (2E)-3-(4-methoxyphenyl)acrylate | |
Other names
Isopentyl 4-methoxycinnamate; Isoamyl p-methoxycinnamate | |
Identifiers | |
71617-10-2 | |
ChEMBL | ChEMBL1476782 |
ChemSpider | 1266578 |
| |
Jmol-3D images | Image |
PubChem | 1549789 |
| |
Properties | |
Molecular formula |
C15H20O3 |
Molar mass | 248.32 g·mol−1 |
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
Infobox references | |
Amiloxate is a sunscreening agent. It is approved for use in the European Union and is undergoing regulatory evaluation in the United States.[1][2]
See also
References
- ↑ Brian Palmer. "Burned by Bureaucracy: Why is the FDA stalling on newer and better sunscreens?". Slate.com.
- ↑ Britt Erickson (May 12, 2014). "Sunscreen Delays". Chemical & Engineering News 92 (19): 27.
|